Finished
Novel Robotic Prostatectomy Technique for Early Urinary Continence
NCT06237114 · Sir Mortimer B. Davis - Jewish General Hospital · Updated 18 April 2025
- What is being tested
- Not stated
- For
- Prostate Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 30 people. The full rules are on the registry page.
- Where
- Canada
- When
- Starts or started 8 March 2024, ends 10 April 2025. Registered 1 Feb 2024.
- Results
- None posted yet.
In the researchers' words
The goal of this a single arm prospective study is to evaluating the 3-month return of urinary continence outcomes of patients undergoing the transvesical retzius sparing robotic radical prostatectomy (TRS-RALP) for standard of care surgical prostate removal for treatment of prostate cancer. The main question it aims: To have patients respond to questionnaires to collect exploratory data on patient's quality of life (QoL; EuroQol-5 Dimension 5-Level \[EQ-5D-5L\] and prostate cancer related urinary, bowel, and sexual function questionnaires (Expanded Prostate cancer Index Composite for Clinical Practice (EPIC-CP), at their standard of care perioperative visits at baseline and at 4 weeks, 3- and 6-months post operatively.
Sites
- Jewish General HospitalMontreal, Quebec, Canada